Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Constance D Lehman, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. P01CA154292 (KERLIKOWSKE, KARLA M) Sep 27, 2011 - Aug 31, 2016
    NIH/NCI
    Risk-Based Breast Cancer Screening in Community Settings
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sippo DA, Sullivan AM, Cohen A, Mercaldo SF, Bahl M, Lehman CD. The Adoption and Impact on Performance of an Automated Outcomes Feedback Application for Tomosynthesis Screening Mammography. J Am Coll Radiol. 2020 Jul 21. PMID: 32707191.
    Citations:    
  2. Lamb LR, Oseni TO, Lehman CD, Bahl M. Pre-operative MRI in patients with ductal carcinoma in situ: Is MRI useful for identifying additional disease? Eur J Radiol. 2020 Aug; 129:109130. PMID: 32634736.
    Citations:    
  3. Kuhl CK, Lehman C, Bedrosian I. Imaging in Locoregional Management of Breast Cancer. J Clin Oncol. 2020 Jul 10; 38(20):2351-2361. PMID: 32442068.
    Citations:    
  4. Oseni TO, Smith BL, Lehman CD, Vijapura CA, Pinnamaneni N, Bahl M. Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma? Ann Surg Oncol. 2020 May 16. PMID: 32418079.
    Citations:    
  5. Panigrahi B, Miles RC, Chou SS, Brackett DG, Sohn YJ, Lehman C. Rare case of invasive lobular carcinoma in a male. Radiol Case Rep. 2020 Jun; 15(6):727-729. PMID: 32304318.
    Citations:    
  6. Bahl M, Mercaldo S, Dang PA, McCarthy AM, Lowry KP, Lehman CD. Breast Cancer Screening with Digital Breast Tomosynthesis: Are Initial Benefits Sustained? Radiology. 2020 06; 295(3):529-539. PMID: 32255414.
    Citations:    
  7. Isakoff SJ, Lehman CD, Shannon KM, Basnet KM. Case 7-2020: A 52-Year-Old Man with a Mass in the Left Breast. N Engl J Med. 2020 Feb 27; 382(9):856-864. PMID: 32101669.
    Citations:    
  8. Dontchos BN, Yala A, Barzilay R, Xiang J, Lehman CD. External Validation of a Deep Learning Model for Predicting Mammographic Breast Density in Routine Clinical Practice. Acad Radiol. 2020 Feb 20. PMID: 32089465.
    Citations:    
  9. Narayan AK, Lehman CD. Mammography Screening Guideline Controversies: Opportunities to Improve Patient Engagement in Screening. J Am Coll Radiol. 2020 May; 17(5):633-636. PMID: 32027838.
    Citations:    
  10. Wang GX, Narayan AK, Park ER, Lehman CD, Gorenstein JT, Flores EJ. Screening Mammography Visits as Opportunities to Engage Smokers With Tobacco Cessation Services and Lung Cancer Screening. J Am Coll Radiol. 2020 May; 17(5):606-612. PMID: 31930983.
    Citations:    
  11. Lopez D, Miles RC, Flores EJ, Lehman CD, Narayan AK. Breast Cancer Screening in Puerto Rico and Other US Territories: Findings from the 2016 Behavioral Risk Factor Surveillance System Survey. J Health Care Poor Underserved. 2020; 31(1):340-352. PMID: 32037335.
    Citations:    
  12. Miles RC, Choi P, Baird GL, Dibble EH, Lamb L, Garg M, Lehman C. Will the Effect of New Federal Breast Density Legislation Be Diminished by Currently Available Online Patient Educational Materials? Acad Radiol. 2019 Dec 12. PMID: 31839567.
    Citations:    
  13. Edmonds CE, Lamb LR, Mercaldo SF, Sippo DA, Burk KS, Lehman CD. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI. AJR Am J Roentgenol. 2020 02; 214(2):240-248. PMID: 31799867.
    Citations:    
  14. Debruhl ND, Lee SJ, Mahoney MC, Hanna L, Tuite C, Gatsonis CA, Lehman C. MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-up. J Breast Imaging. 2020 Feb; 2(1):50-55. PMID: 32055797.
    Citations:    
  15. Lamb LR, Lehman CD, Oseni TO, Bahl M. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma. Acad Radiol. 2019 Nov 04. PMID: 31699638.
    Citations:    
  16. Miles RC, Lehman CD, Mercaldo SF, Tamimi RM, Dontchos BN, Narayan AK. Obesity and breast cancer screening: Cross-sectional survey results from the behavioral risk factor surveillance system. Cancer. 2019 Dec 01; 125(23):4158-4163. PMID: 31393609.
    Citations:    
  17. Yala A, Schuster T, Miles R, Barzilay R, Lehman C. A Deep Learning Model to Triage Screening Mammograms: A Simulation Study. Radiology. 2019 10; 293(1):38-46. PMID: 31385754.
    Citations:    
  18. Sippo DA, Rutledge GM, Mercaldo SF, Burk KS, Edmonds CE, Dang PA, Lehman CD. Impact of Background Parenchymal Enhancement on Diagnostic Performance in Screening Breast MRI. Acad Radiol. 2020 05; 27(5):663-671. PMID: 31327575.
    Citations:    
  19. Lam DL, Smith J, Partridge SC, Kim A, Javid SH, Hippe DS, Lehman CD, Lee JM, Rahbar H. The Impact of Preoperative Breast MRI on Surgical Management of Women with Newly Diagnosed Ductal Carcinoma In Situ. Acad Radiol. 2020 04; 27(4):478-486. PMID: 31281083.
    Citations:    
  20. Lehman CD, Gatsonis C, Romanoff J, Khan SA, Carlos R, Solin LJ, Badve S, McCaskill-Stevens W, Corsetti RL, Rahbar H, Spell DW, Blankstein KB, Han LK, Sabol JL, Bumberry JR, Gareen I, Snyder BS, Wagner LI, Miller KD, Sparano JA, Comstock C. Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment. JAMA Oncol. 2019 Jul 01; 5(7):1036-1042. PMID: 30653209.
    Citations:    Fields:    
  21. Dontchos BN, Rahbar H, Partridge SC, Lehman CD, DeMartini WB. Influence of Menstrual Cycle Timing on Screening Breast MRI Background Parenchymal Enhancement and Diagnostic Performance in Premenopausal Women. J Breast Imaging. 2019 Sep; 1(3):205-211. PMID: 31538142.
    Citations:    
  22. Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 08; 292(2):311-318. PMID: 31161975.
    Citations:    
  23. Dontchos BN, Narayan AK, Seidler M, Mercaldo SF, Miles RC, Ebert E, Lehman CD. Impact of a Same-Day Breast Biopsy Program on Disparities in Time to Biopsy. J Am Coll Radiol. 2019 Nov; 16(11):1554-1560. PMID: 31152690.
    Citations:    
  24. Choudhery S, Chou SS, Chang K, Kalpathy-Cramer J, Lehman CD. Kinetic Analysis of Lesions Identified on a Rapid Abridged Multiphase (RAMP) Breast MRI Protocol. Acad Radiol. 2020 05; 27(5):672-681. PMID: 31147233.
    Citations:    
  25. López DB, Flores EJ, Miles RC, Wang GX, Glover M, Shepard JO, Lehman CD, Narayan AK. Assessing Eligibility for Lung Cancer Screening Among Women Undergoing Screening Mammography: Cross-Sectional Survey Results From the National Health Interview Survey. J Am Coll Radiol. 2019 Oct; 16(10):1433-1439. PMID: 31092347.
    Citations:    
  26. Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R. A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction. Radiology. 2019 07; 292(1):60-66. PMID: 31063083.
    Citations:    
  27. Sippo DA, Burk KS, Mercaldo SF, Rutledge GM, Edmonds C, Guan Z, Hughes KS, Lehman CD. Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications. Radiology. 2019 07; 292(1):51-59. PMID: 31063080.
    Citations:    
  28. Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk. JAMA Intern Med. 2019 05 01; 179(5):658-667. PMID: 30882843.
    Citations:    
  29. Bahl M, Lehman CD. Breast Cancer Screening Using Digital Breast Tomosynthesis: Not All Mammography Is Equal. JAMA Oncol. 2019 05 01; 5(5):642-643. PMID: 30816932.
    Citations:    
  30. Bahl M, Pinnamaneni N, Mercaldo S, McCarthy AM, Lehman CD. Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States. Radiology. 2019 06; 291(3):582-590. PMID: 30938625.
    Citations:    
  31. Portnoi T, Yala A, Schuster T, Barzilay R, Dontchos B, Lamb L, Lehman C. Deep Learning Model to Assess Cancer Risk on the Basis of a Breast MR Image Alone. AJR Am J Roentgenol. 2019 Apr 01; 1-7. PMID: 30933651.
    Citations:    
  32. Narayan AK, Lopez DB, Miles RC, Dontchos B, Flores EJ, Glover M, Lehman CD. Implementation of an Intimate Partner Violence Screening Assessment and Referral System in an Academic Women's Imaging Department. J Am Coll Radiol. 2019 Apr; 16(4 Pt B):631-634. PMID: 30947898.
    Citations:    
  33. Sippo DA, Rutledge GM, Burk KS, Mercaldo SF, Dontchos BN, Edmonds CE, Lehman CD. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI. AJR Am J Roentgenol. 2019 03 19; 212(6):1412-1418. PMID: 30888867.
    Citations:    
  34. Cui C, Chou SS, Brattain L, Lehman CD, Samir AE. Data Engineering for Machine Learning in Women's Imaging and Beyond. AJR Am J Roentgenol. 2019 Feb 19; 1-10. PMID: 30779668.
    Citations:    
  35. Flores EJ, López D, Miles RC, Glover M, Lehman CD, Harvey HB, Narayan AK. Impact of Primary Care Physician Interaction on Longitudinal Adherence to Screening Mammography Across Different Racial/Ethnic Groups. J Am Coll Radiol. 2019 Jul; 16(7):908-914. PMID: 30737162.
    Citations:    
  36. Lee JM, Partridge SC, Liao GJ, Hippe DS, Kim AE, Lee CI, Rahbar H, Scheel JR, Lehman CD. Double reading of automated breast ultrasound with digital mammography or digital breast tomosynthesis for breast cancer screening. Clin Imaging. 2019 May - Jun; 55:119-125. PMID: 30807927.
    Citations:    
  37. Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, Harvey SM, Moy L, DeMartini WB, Dogan B, Yang WT, Wang LC, Joe BN, Oh KY, Neal CH, McDonald ES, Schnall MD, Lehman CD, Comstock CE, Partridge SC. Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702). Clin Cancer Res. 2019 03 15; 25(6):1756-1765. PMID: 30647080.
    Citations:    Fields:    
  38. Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk. J Clin Oncol. 2019 04 20; 37(12):954-963. PMID: 30625040.
    Citations:    Fields:    
  39. Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA. Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063. PMID: 30627695.
    Citations:    
  40. Miles RC, Narayan AK, Lopez DB, Lehman CD, Harvey HB, Mishra V, Glover M, Flores EJ. Chronic Medical Illness as a Risk Factor for Poor Mammography Screening Adherence. J Womens Health (Larchmt). 2019 10; 28(10):1378-1383. PMID: 30565970.
    Citations:    Fields:    
  41. Roark AA, Dang PA, Niell BL, Halpern EF, Lehman CD. Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer. AJR Am J Roentgenol. 2019 02; 212(2):271-279. PMID: 30540208.
    Citations:    Fields:    
  42. Bahl M, Maunglay M, D'Alessandro HA, Lehman CD. Comparison of Upright Digital Breast Tomosynthesis-guided versus Prone Stereotactic Vacuum-assisted Breast Biopsy. Radiology. 2019 02; 290(2):298-304. PMID: 30511909.
    Citations:    Fields:    
  43. Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE. Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population. J Womens Health (Larchmt). 2019 08; 28(8):1051-1059. PMID: 30481098.
    Citations:    Fields:    
  44. Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, Garber JE, Gray R, Greenberg CC, Greenup R, Hansen NM, Harris RE, Heerdt AS, Helsten T, Hodgkiss L, Hoyt TL, Huff JG, Jacobs L, Lehman CD, Monsees B, Niell BL, Parker CC, Pearlman M, Philpotts L, Shepardson LB, Smith ML, Stein M, Tumyan L, Williams C, Bergman MA, Kumar R. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 11; 16(11):1362-1389. PMID: 30442736.
    Citations:    Fields:    
  45. Lehman CD, Yala A, Schuster T, Dontchos B, Bahl M, Swanson K, Barzilay R. Mammographic Breast Density Assessment Using Deep Learning: Clinical Implementation. Radiology. 2019 01; 290(1):52-58. PMID: 30325282.
    Citations:    Fields:    
  46. Chen Y, Chou SS, Blaschke EM, Specht MC, Lehman CD. Value of Mammography for Women 30-39 Years Old Presenting With Breast Symptoms. AJR Am J Roentgenol. 2018 12; 211(6):1416-1424. PMID: 30300000.
    Citations:    Fields:    
  47. Lamb LR, Bahl M, Lehman CD. Evaluation of a Nonradioactive Magnetic Marker Wireless Localization Program. AJR Am J Roentgenol. 2018 10; 211(4):W202. PMID: 30240319.
    Citations:    Fields:    
  48. Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL. The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume. AJR Am J Roentgenol. 2018 11; 211(5):957-963. PMID: 30235000.
    Citations:    Fields:    
  49. Narayan AK, Elkin EB, Lehman CD, Morris EA. Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines. Breast Cancer Res Treat. 2018 Nov; 172(2):463-468. PMID: 30128821.
    Citations:    Fields:    Translation:HumansPHPublic Health
  50. Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-Reported Breast Density Awareness and Knowledge after Breast Density Legislation Passage. Acad Radiol. 2019 06; 26(6):726-731. PMID: 30122625.
    Citations:    Fields:    
  51. Lamb LR, Bahl M, Specht MC, D'Alessandro HA, Lehman CD. Evaluation of a Nonradioactive Magnetic Marker Wireless Localization Program. AJR Am J Roentgenol. 2018 10; 211(4):940-945. PMID: 30085842.
    Citations:    Fields:    
  52. Narayan AK, Flores EJ, Harvey HB, Lehman CD. Population-Based Health Engagement Opportunities Through Breast Imaging: A Population-Based Cross-Sectional Survey. J Am Coll Radiol. 2018 Oct; 15(10):1401-1407. PMID: 30061047.
    Citations:    Fields:    
  53. Bahl M, Mercaldo S, Vijapura CA, McCarthy AM, Lehman CD. Comparison of performance metrics with digital 2D versus tomosynthesis mammography in the diagnostic setting. Eur Radiol. 2019 Feb; 29(2):477-484. PMID: 29967957.
    Citations:    Fields:    
  54. Lowry KP, Braunstein LZ, Economopoulos KP, Salama L, Lehman CD, Gazelle GS, Halpern EF, Giess CS, Taghian AG, Lee JM. Predictors of surveillance mammography outcomes in women with a personal history of breast cancer. Breast Cancer Res Treat. 2018 Aug; 171(1):209-215. PMID: 29748762.
    Citations:    Fields:    
  55. Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol. 2018 07 10; 36(20):2070-2077. PMID: 29718790.
    Citations:    Fields:    
  56. Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. AJR Am J Roentgenol. 2018 Jun; 210(6):1376-1385. PMID: 29708782.
    Citations:    Fields:    
  57. Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. JAMA Intern Med. 2018 04 01; 178(4):458-468. PMID: 29435556.
    Citations:    Fields:    
  58. Lamb LR, Bahl M, Hughes KS, Lehman CD. Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography. J Am Coll Surg. 2018 05; 226(5):858-867. PMID: 29410346.
    Citations:    Fields:    
  59. Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):748-754. PMID: 29341851.
    Citations:    Fields:    Translation:Humans
  60. Bahl M, Gaffney S, McCarthy AM, Lowry KP, Dang PA, Lehman CD. Breast Cancer Characteristics Associated with 2D Digital Mammography versus Digital Breast Tomosynthesis for Screening-detected and Interval Cancers. Radiology. 2018 Apr; 287(1):49-57. PMID: 29272213.
    Citations:    Fields:    Translation:HumansPHPublic Health
  61. Lamb LR, Bahl M, Gadd MA, Lehman CD. Flat Epithelial Atypia: Upgrade Rates and Risk-Stratification Approach to Support Informed Decision Making. J Am Coll Surg. 2017 Dec; 225(6):696-701. PMID: 29100673.
    Citations:    Fields:    Translation:Humans
  62. Bahl M, Barzilay R, Yedidia AB, Locascio NJ, Yu L, Lehman CD. High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision. Radiology. 2018 Mar; 286(3):810-818. PMID: 29039725.
    Citations: 1     Fields:    Translation:Humans
  63. Luo J, Johnston BS, Kitsch AE, Hippe DS, Korde LA, Javid S, Lee JM, Peacock S, Lehman CD, Partridge SC, Rahbar H. Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment. Radiology. 2017 12; 285(3):788-797. PMID: 28914599.
    Citations: 1     Fields:    Translation:Humans
  64. Bahl M, Gadd MA, Lehman CD. JOURNAL CLUB: Diagnostic Utility of MRI After Negative or Inconclusive Mammography for the Evaluation of Pathologic Nipple Discharge. AJR Am J Roentgenol. 2017 Dec; 209(6):1404-1410. PMID: 28898125.
    Citations:    Fields:    Translation:Humans
  65. Bahl M, Lamb LR, Lehman CD. Pathologic Outcomes of Architectural Distortion on Digital 2D Versus Tomosynthesis Mammography. AJR Am J Roentgenol. 2017 Nov; 209(5):1162-1167. PMID: 28834441.
    Citations:    Fields:    Translation:Humans
  66. Lee JM, Miglioretti DL, Burnside ES, Morris EA, Smith RA, Lehman CD. Mammography Performance Benchmarks in an Era of Value-based Care. Radiology. 2017 08; 284(2):605-607. PMID: 28723290.
    Citations:    Fields:    Translation:HumansPHPublic Health
  67. Scheel JR, Molina Y, Anderson BO, Patrick DL, Nakigudde G, Gralow JR, Lehman CD, Thompson B. Breast Cancer Beliefs as Potential Targets for Breast Cancer Awareness Efforts to Decrease Late-Stage Presentation in Uganda. J Glob Oncol. 2018 09; 4:1-9. PMID: 30241166.
    Citations:    Fields:    
  68. Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52. PMID: 28582633.
    Citations: 2     Fields:    Translation:Humans
  69. Scheel JR, Molina Y, Patrick DL, Anderson BO, Nakigudde G, Lehman CD, Thompson B. Breast Cancer Downstaging Practices and Breast Health Messaging Preferences Among a Community Sample of Urban and Rural Ugandan Women. J Glob Oncol. 2017 Apr; 3(2):105-113. PMID: 28503660.
    Citations: 1     Fields:    
  70. Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017 04; 283(1):59-69. PMID: 28244803.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  71. Catalano OA, Horn GL, Signore A, Iannace C, Lepore M, Vangel M, Luongo A, Catalano M, Lehman C, Salvatore M, Soricelli A, Catana C, Mahmood U, Rosen BR. PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype. Br J Cancer. 2017 Mar 28; 116(7):893-902. PMID: 28208155.
    Citations: 2     Fields:    Translation:Humans
  72. Scheel JR, Molina Y, Coronado G, Bishop S, Doty S, Jimenez R, Thompson B, Lehman CD, Beresford SA. Healthcare Factors for Obtaining a Mammogram in Latinas With a Variable Mammography History. Oncol Nurs Forum. 2017 01 01; 44(1):66-76. PMID: 27991613.
    Citations: 1     Fields:    Translation:Humans
  73. Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM. MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial. J Magn Reson Imaging. 2017 07; 46(1):290-302. PMID: 27981651.
    Citations: 5     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  74. Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017 04; 283(1):49-58. PMID: 27918707.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  75. Yala A, Barzilay R, Salama L, Griffin M, Sollender G, Bardia A, Lehman C, Buckley JM, Coopey SB, Polubriaginof F, Garber JE, Smith BL, Gadd MA, Specht MC, Gudewicz TM, Guidi AJ, Taghian A, Hughes KS. Using machine learning to parse breast pathology reports. Breast Cancer Res Treat. 2017 01; 161(2):203-211. PMID: 27826755.
    Citations: 3     Fields:    Translation:Humans
  76. Lee CI, Lehman CD. Digital Breast Tomosynthesis and the Challenges of Implementing an Emerging Breast Cancer Screening Technology Into Clinical Practice. J Am Coll Radiol. 2016 Nov; 13(11S):R61-R66. PMID: 27814817.
    Citations:    Fields:    Translation:Humans
  77. Huynh PT, Lemeshko SV, Mahoney MC, Newell MS, Bailey L, Barke LD, D'Orsi C, Harvey JA, Hayes MK, Jokich PM, Lee SJ, Lehman CD, Mainiero MB, Mankoff DA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG. ACR Appropriateness Criteria® Stage I Breast Carcinoma. J Am Coll Radiol. 2016 Nov; 13(11S):e53-e57. PMID: 27814824.
    Citations:    Fields:    Translation:HumansPHPublic Health
  78. Harvey JA, Mahoney MC, Newell MS, Bailey L, Barke LD, D'Orsi C, Hayes MK, Jokich PM, Lee SJ, Lehman CD, Mainiero MB, Mankoff DA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG. ACR Appropriateness Criteria Palpable Breast Masses. J Am Coll Radiol. 2016 Nov; 13(11S):e31-e42. PMID: 27814822.
    Citations: 2     Fields:    Translation:Humans
  79. Mainiero MB, Lourenco A, Mahoney MC, Newell MS, Bailey L, Barke LD, D'Orsi C, Harvey JA, Hayes MK, Huynh PT, Jokich PM, Lee SJ, Lehman CD, Mankoff DA, Nepute JA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG. ACR Appropriateness Criteria Breast Cancer Screening. J Am Coll Radiol. 2016 Nov; 13(11S):R45-R49. PMID: 27814813.
    Citations: 7     Fields:    Translation:Humans
  80. Lee CI, Bensink ME, Berry K, Musa Z, Bodnar C, Dann R, Jarvik JG, Lehman CD, Ramsey SD. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences. J Am Coll Radiol. 2016 Nov; 13(11S):R81-R88. PMID: 27814820.
    Citations: 1     Fields:    Translation:Humans
  81. Sprague BL, Conant EF, Onega T, Garcia MP, Beaber EF, Herschorn SD, Lehman CD, Tosteson AN, Lacson R, Schnall MD, Kontos D, Haas JS, Weaver DL, Barlow WE. Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. Ann Intern Med. 2016 Oct 04; 165(7):457-464. PMID: 27428568.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  82. Scheel JR, Peacock S, Orem J, Bugeza S, Muyinda Z, Porter PL, Wood WC, Comis RL, Lehman CD. Improving Breast Ultrasound Interpretation in Uganda Using a Condensed Breast Imaging Reporting and Data System. Acad Radiol. 2016 10; 23(10):1271-7. PMID: 27325412.
    Citations: 1     Fields:    Translation:Humans
  83. Rahbar H, Kurland BF, Olson ML, Kitsch AE, Scheel JR, Chai X, Usoro J, Lehman CD, Partridge SC. Diffusion-Weighted Breast Magnetic Resonance Imaging: A Semiautomated Voxel Selection Technique Improves Interreader Reproducibility of Apparent Diffusion Coefficient Measurements. J Comput Assist Tomogr. 2016 May-Jun; 40(3):428-35. PMID: 27192501.
    Citations: 2     Fields:    Translation:Humans
  84. McDonald ES, Hammersley JA, Chou SH, Rahbar H, Scheel JR, Lee CI, Liu CL, Lehman CD, Partridge SC. Performance of DWI as a Rapid Unenhanced Technique for Detecting Mammographically Occult Breast Cancer in Elevated-Risk Women With Dense Breasts. AJR Am J Roentgenol. 2016 Jul; 207(1):205-16. PMID: 27077731.
    Citations: 5     Fields:    Translation:Humans
  85. Lehman C. Potential Benefits of Computer-Aided Detection for Cancer Identification and Treatment-Reply. JAMA Intern Med. 2016 Mar; 176(3):411. PMID: 26954046.
    Citations:    Fields:    Translation:Humans
  86. Taouli B, Beer AJ, Chenevert T, Collins D, Lehman C, Matos C, Padhani AR, Rosenkrantz AB, Shukla-Dave A, Sigmund E, Tanenbaum L, Thoeny H, Thomassin-Naggara I, Barbieri S, Corcuera-Solano I, Orton M, Partridge SC, Koh DM. Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop. J Magn Reson Imaging. 2016 09; 44(3):521-40. PMID: 26892827.
    Citations: 24     Fields:    Translation:Humans
  87. Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, Porter P, Gralow J, Partridge SC. Screening MRI in Women With a Personal History of Breast Cancer. J Natl Cancer Inst. 2016 Mar; 108(3). PMID: 26744477.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  88. Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, Wernli KJ, Sprague BL, Herschorn SD, Lehman CD. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol. 2016 Jan; 206(1):211-6. PMID: 26700354.
    Citations:    Fields:    Translation:HumansPHPublic Health
  89. Rahbar H, Lehman CD. Rethinking Preoperative Breast Magnetic Resonance Imaging. JAMA Oncol. 2015 Dec; 1(9):1226-7. PMID: 26401621.
    Citations: 3     Fields:    Translation:Humans
  90. Scheel JR, Molina Y, Briant KJ, Ibarra G, Lehman CD, Thompson B. Latinas' Mammography Intention Following a Home-Based Promotores-Led Intervention. J Community Health. 2015 Dec; 40(6):1185-92. PMID: 26063674.
    Citations: 4     Fields:    Translation:Humans
  91. Hylton NM, Gatsonis CA, Rosen MA, Lehman CD, Newitt DC, Partridge SC, Bernreuter WK, Pisano ED, Morris EA, Weatherall PT, Polin SM, Newstead GM, Marques HS, Esserman LJ, Schnall MD. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology. 2016 Apr; 279(1):44-55. PMID: 26624971.
    Citations: 16     Fields:    Translation:Humans
  92. Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. JAMA Intern Med. 2015 Nov; 175(11):1828-37. PMID: 26414882.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  93. Henderson LM, Weiss J, Hubbard RA, O'Donoghue C, DeMartini WB, Buist DS, Kerlikowske K, Goodrich M, Virnig B, Tosteson AN, Lehman CD, Onega T. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer. Breast J. 2016 Jan-Feb; 22(1):24-34. PMID: 26511204.
    Citations: 3     Fields:    Translation:Humans
  94. Scheel JR, Nealey EM, Orem J, Bugeza S, Muyinda Z, Nathan RO, Porter PL, Lehman CD. ACR BI-RADS Use in Low-Income Countries: An Analysis of Diagnostic Breast Ultrasound Practice in Uganda. J Am Coll Radiol. 2016 Feb; 13(2):163-9. PMID: 26419306.
    Citations:    Fields:    Translation:Humans
  95. Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol. 2015 Sep; 205(3):676-84. PMID: 26295657.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  96. Morris E, Feig SA, Drexler M, Lehman C. Implications of Overdiagnosis: Impact on Screening Mammography Practices. Popul Health Manag. 2015 Sep; 18 Suppl 1:S3-11. PMID: 26414384.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  97. Rahbar H, Parsian S, Lam DL, Dontchos BN, Andeen NK, Rendi MH, Lehman CD, Partridge SC. Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ? Clin Imaging. 2016 Jan-Feb; 40(1):125-9. PMID: 26365872.
    Citations: 1     Fields:    Translation:Humans
  98. Lee CI, Bogart A, Germino JC, Goldman LE, Hubbard RA, Haas JS, Hill DA, Tosteson AN, Alford-Teaster JA, DeMartini WB, Lehman CD, Onega TL. Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations. J Med Screen. 2016 Mar; 23(1):24-30. PMID: 26078275.
    Citations:    Fields:    Translation:Humans
  99. Sprague BL, Lehman CD, Tosteson AN. Supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015 Jun 02; 162(11):802-3. PMID: 26030643.
    Citations:    Fields:    Translation:HumansPHPublic Health
  100. Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, Miglioretti DL. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015 May 19; 162(10):673-81. PMID: 25984843.
    Citations: 34     Fields:    Translation:HumansPHPublic Health
  101. Dontchos BN, Rahbar H, Partridge SC, Korde LA, Lam DL, Scheel JR, Peacock S, Lehman CD. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk? Radiology. 2015 Aug; 276(2):371-80. PMID: 25965809.
    Citations: 23     Fields:    Translation:Humans
  102. Lee JM, Buist DS, Houssami N, Dowling EC, Halpern EF, Gazelle GS, Lehman CD, Henderson LM, Hubbard RA. Five-year risk of interval-invasive second breast cancer. J Natl Cancer Inst. 2015 Jul; 107(7). PMID: 25904721.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  103. Lee CI, Bogart A, Hubbard RA, Obadina ET, Hill DA, Haas JS, Tosteson AN, Alford-Teaster JA, Sprague BL, DeMartini WB, Lehman CD, Onega TL. Advanced Breast Imaging Availability by Screening Facility Characteristics. Acad Radiol. 2015 Jul; 22(7):846-52. PMID: 25851643.
    Citations: 1     Fields:    Translation:Humans
  104. Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015 Feb 03; 162(3):157-66. PMID: 25486550.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
  105. Nguyen VT, Rahbar H, Olson ML, Liu CL, Lehman CD, Partridge SC. Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla. J Magn Reson Imaging. 2015 Sep; 42(3):788-800. PMID: 25611726.
    Citations: 5     Fields:    Translation:Humans
  106. Rahbar H, DeMartini WB, Lee AY, Partridge SC, Peacock S, Lehman CD. Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS. Eur J Radiol. 2015 Apr; 84(4):611-6. PMID: 25604909.
    Citations: 4     Fields:    Translation:Humans
  107. Rahbar H, Conlin JL, Parsian S, DeMartini WB, Peacock S, Lehman CD, Partridge SC. Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign? Acad Radiol. 2015 Apr; 22(4):430-8. PMID: 25491740.
    Citations: 2     Fields:    Translation:Humans
  108. Lam DL, Pandharipande PV, Lee JM, Lehman CD, Lee CI. Imaging-based screening: understanding the controversies. AJR Am J Roentgenol. 2014 Nov; 203(5):952-6. PMID: 25341132.
    Citations: 2     Fields:    Translation:Humans
  109. Lehman CD, Lee AY, Lee CI. Imaging management of palpable breast abnormalities. AJR Am J Roentgenol. 2014 Nov; 203(5):1142-53. PMID: 25341156.
    Citations: 1     Fields:    Translation:Humans
  110. Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology. 2015 Mar; 274(3):772-80. PMID: 25350548.
    Citations: 18     Fields:    Translation:Humans
  111. Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol. 2014 Nov; 21(11):1370-6. PMID: 25126973.
    Citations: 3     Fields:    Translation:Humans
  112. Partridge SC, Stone KM, Strigel RM, DeMartini WB, Peacock S, Lehman CD. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions. Acad Radiol. 2014 Sep; 21(9):1195-203. PMID: 24998690.
    Citations: 3     Fields:    Translation:Humans
  113. Scheel JR, Lee JM, Sprague BL, Lee CI, Lehman CD. Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. Am J Obstet Gynecol. 2015 Jan; 212(1):9-17. PMID: 24959654.
    Citations: 16     Fields:    Translation:Humans
  114. Rahbar H, Hanna LG, Gatsonis C, Mahoney MC, Schnall MD, DeMartini WB, Lehman CD. Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics. Radiology. 2014 Oct; 273(1):53-60. PMID: 24937691.
    Citations: 1     Fields:    Translation:Humans
  115. McDonald ES, Schopp JG, Peacock S, DeMartini WB, DeMartini WD, Rahbar H, Lehman CD, Partridge SC. Diffusion-weighted MRI: association between patient characteristics and apparent diffusion coefficients of normal breast fibroglandular tissue at 3 T. AJR Am J Roentgenol. 2014 May; 202(5):W496-502. PMID: 24758685.
    Citations: 9     Fields:    Translation:Humans
  116. Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32. PMID: 24247555.
    Citations: 29     Fields:    Translation:Humans
  117. Loiselle C, Eby PR, Kim JN, Calhoun KE, Allison KH, Gadi VK, Peacock S, Storer BE, Mankoff DA, Partridge SC, Lehman CD. Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy. Acad Radiol. 2014 Jan; 21(1):92-8. PMID: 24331270.
    Citations: 4     Fields:    Translation:Humans
  118. Lee CI, Bensink ME, Berry K, Musa Z, Bodnar C, Dann R, Jarvik JG, Lehman CD, Ramsey SD. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences. J Am Coll Radiol. 2013 Dec; 10(12):924-30. PMID: 24295942.
    Citations: 2     Fields:    Translation:Humans
  119. Lee CI, Lehman CD. Digital breast tomosynthesis and the challenges of implementing an emerging breast cancer screening technology into clinical practice. J Am Coll Radiol. 2013 Dec; 10(12):913-7. PMID: 24295940.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  120. Stewart FM, Lehman C, Carlos T, Chen EY, Jensen B, Rieke JW, Greer BE, Bredeson C, Putnam K, Ramsey SD. Stakeholder-informed "Choosing Wisely" implementation project in regional oncology clinics. J Clin Oncol. 2013 Nov; 31(31_suppl):207. PMID: 28136503.
    Citations:    
  121. Harvey JA, Mahoney MC, Newell MS, Bailey L, Barke LD, D'Orsi C, Hayes MK, Jokich PM, Lee SJ, Lehman CD, Mainiero MB, Mankoff DA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG. ACR appropriateness criteria palpable breast masses. J Am Coll Radiol. 2013 Oct; 10(10):742-9.e1-3. PMID: 24091044.
    Citations: 1     Fields:    Translation:Humans
  122. O'Leary CB, Lehman C, Koltun K, Smith-Ryan A, Hackney AC. Response of testosterone to prolonged aerobic exercise during different phases of the menstrual cycle. Eur J Appl Physiol. 2013 Sep; 113(9):2419-24. PMID: 23812088.
    Citations: 2     Fields:    Translation:Humans
  123. Lehman CD, Blume JD, DeMartini WB, Hylton NM, Herman B, Schnall MD. Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers. AJR Am J Roentgenol. 2013 Jun; 200(6):W683-9. PMID: 23701102.
    Citations: 6     Fields:    Translation:Humans
  124. Lee CI, Grauke LJ, Sandhir V, Demartini WB, Newstead GM, Peacock S, Lehman CD. Radiologists' performance in the ACR Breast MR With Guided Biopsy course. J Am Coll Radiol. 2013 Nov; 10(11):854-8. PMID: 23714721.
    Citations:    Fields:    Translation:Humans
  125. Brandão AC, Lehman CD, Partridge SC. Breast magnetic resonance imaging: diffusion-weighted imaging. Magn Reson Imaging Clin N Am. 2013 May; 21(2):321-36. PMID: 23642556.
    Citations: 10     Fields:    Translation:Humans
  126. Rahbar H, Partridge SC, DeMartini WB, Thursten B, Lehman CD. Clinical and technical considerations for high quality breast MRI at 3 Tesla. J Magn Reson Imaging. 2013 Apr; 37(4):778-90. PMID: 23526757.
    Citations: 8     Fields:    Translation:Humans
  127. Morris EA, Kuhl CK, Lehman CD. Ensuring high-quality breast MR imaging technique and interpretation. Radiology. 2013 Mar; 266(3):996-7. PMID: 23431233.
    Citations:    Fields:    Translation:Humans
  128. Lee CI, Bassett LW, Lehman CD. Response. Radiology. 2013 Mar; 266(3):999-1000. PMID: 23550288.
    Citations:    Fields:    Translation:HumansPHPublic Health
  129. Koon KP, Lehman CD, Gralow JR. The importance of survivors and partners in improving breast cancer outcomes in Uganda. Breast. 2013 Apr; 22(2):138-141. PMID: 23313061.
    Citations: 3     Fields:    Translation:Humans
  130. Mainiero MB, Lourenco A, Mahoney MC, Newell MS, Bailey L, Barke LD, D'Orsi C, Harvey JA, Hayes MK, Huynh PT, Jokich PM, Lee SJ, Lehman CD, Mankoff DA, Nepute JA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG. ACR Appropriateness Criteria Breast Cancer Screening. J Am Coll Radiol. 2013 Jan; 10(1):11-4. PMID: 23290667.
    Citations: 29     Fields:    Translation:Humans
  131. Lehman CD, Lee CI, Loving VA, Portillo MS, Peacock S, DeMartini WB. Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women 30-39 years of age. AJR Am J Roentgenol. 2012 Nov; 199(5):1169-77. PMID: 23096195.
    Citations: 8     Fields:    Translation:Humans
  132. Parsian S, Rahbar H, Allison KH, Demartini WB, Olson ML, Lehman CD, Partridge SC. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology. 2012 Dec; 265(3):696-706. PMID: 23033500.
    Citations: 17     Fields:    Translation:Humans
  133. Rahbar H, Partridge SC, Javid SH, Lehman CD. Imaging axillary lymph nodes in patients with newly diagnosed breast cancer. Curr Probl Diagn Radiol. 2012 Sep-Oct; 41(5):149-58. PMID: 22818835.
    Citations: 6     Fields:    Translation:Humans
  134. Lehman CD. Clinical indications: what is the evidence? Eur J Radiol. 2012 Sep; 81 Suppl 1:S82-4. PMID: 23083615.
    Citations:    Fields:    Translation:Humans
  135. DeMartini WB, Hanna L, Gatsonis C, Mahoney MC, Lehman CD. Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trial. AJR Am J Roentgenol. 2012 Sep; 199(3):W386-91. PMID: 22915431.
    Citations: 3     Fields:    Translation:Humans
  136. Lehman CD. Diffusion weighted imaging (DWI) of the breast: ready for clinical practice? Eur J Radiol. 2012 Sep; 81 Suppl 1:S80-1. PMID: 23083614.
    Citations: 2     Fields:    Translation:Humans
  137. Gutierrez RL, Strigel RM, Partridge SC, DeMartini WB, Eby PR, Stone KM, Peacock S, Lehman CD. Dynamic breast MRI: does lower temporal resolution negatively affect clinical kinetic analysis? AJR Am J Roentgenol. 2012 Sep; 199(3):703-8. PMID: 22915415.
    Citations: 6     Fields:    Translation:Humans
  138. Lee CI, Bassett LW, Lehman CD. Breast density legislation and opportunities for patient-centered outcomes research. Radiology. 2012 Sep; 264(3):632-6. PMID: 22919037.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  139. Huynh PT, Lemeshko SV, Mahoney MC, Newell MS, Bailey L, Barke LD, D'Orsi C, Harvey JA, Hayes MK, Jokich PM, Lee SJ, Lehman CD, Mainiero MB, Mankoff DA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG. ACR Appropriateness Criteria® stage I breast carcinoma. J Am Coll Radiol. 2012 Jul; 9(7):463-7. PMID: 22748785.
    Citations:    Fields:    Translation:HumansPHPublic Health
  140. Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, Weatherall PT, Lehman CD, Newstead GM, Polin S, Marques HS, Esserman LJ, Schnall MD. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology. 2012 Jun; 263(3):663-72. PMID: 22623692.
    Citations: 81     Fields:    Translation:Humans
  141. Esserman LJ, Berry DA, DeMichele A, Carey L, Davis SE, Buxton M, Hudis C, Gray JW, Perou C, Yau C, Livasy C, Krontiras H, Montgomery L, Tripathy D, Lehman C, Liu MC, Olopade OI, Rugo HS, Carpenter JT, Dressler L, Chhieng D, Singh B, Mies C, Rabban J, Chen YY, Giri D, van 't Veer L, Hylton N. Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. J Clin Oncol. 2012 Sep 10; 30(26):3242-9. PMID: 22649152.
    Citations: 95     Fields:    Translation:Humans
  142. Mahoney MC, Gatsonis C, Hanna L, DeMartini WB, Lehman C. Positive predictive value of BI-RADS MR imaging. Radiology. 2012 Jul; 264(1):51-8. PMID: 22589320.
    Citations: 37     Fields:    Translation:Humans
  143. Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters. Radiology. 2012 May; 263(2):374-82. PMID: 22517955.
    Citations: 22     Fields:    Translation:Humans
  144. DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD. Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR Am J Roentgenol. 2012 Apr; 198(4):W373-80. PMID: 22451576.
    Citations: 30     Fields:    Translation:Humans
  145. Brown SD, Lehman CD, Truog RD, Browning DM, Gallagher TH. Stepping out further from the shadows: disclosure of harmful radiologic errors to patients. Radiology. 2012 Feb; 262(2):381-6. PMID: 22282177.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  146. Rahbar H, Partridge SC, Demartini WB, Gutierrez RL, Parsian S, Lehman CD. Improved B1 homogeneity of 3 Tesla breast MRI using dual-source parallel radiofrequency excitation. J Magn Reson Imaging. 2012 May; 35(5):1222-6. PMID: 22282269.
    Citations: 10     Fields:    Translation:Humans
  147. Esserman LJ, Berry DA, Cheang MC, Yau C, Perou CM, Carey L, DeMichele A, Gray JW, Conway-Dorsey K, Lenburg ME, Buxton MB, Davis SE, van't Veer LJ, Hudis C, Chin K, Wolf D, Krontiras H, Montgomery L, Tripathy D, Lehman C, Liu MC, Olopade OI, Rugo HS, Carpenter JT, Livasy C, Dressler L, Chhieng D, Singh B, Mies C, Rabban J, Chen YY, Giri D, Au A, Hylton N. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat. 2012 Apr; 132(3):1049-62. PMID: 22198468.
    Citations: 111     Fields:    Translation:Humans
  148. Parsian S, Rahbar H, Rendi MH, Lehman CD. Benign breast cyst without associated gynecomastia in a male patient: a case report. J Radiol Case Rep. 2011; 5(11):35-40. PMID: 22470772.
    Citations: 1     Fields:    Translation:Humans
  149. Kerlikowske K, Hubbard RA, Miglioretti DL, Geller BM, Yankaskas BC, Lehman CD, Taplin SH, Sickles EA. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011 Oct 18; 155(8):493-502. PMID: 22007043.
    Citations: 61     Fields:    Translation:Humans
  150. Partridge SC, Singer L, Sun R, Wilmes LJ, Klifa CS, Lehman CD, Hylton NM. Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements. Magn Reson Imaging. 2011 Nov; 29(9):1215-21. PMID: 21920686.
    Citations: 17     Fields:    Translation:HumansCells
  151. Rendi MH, Dintzis SM, Lehman CD, Calhoun KE, Allison KH. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol. 2012 Mar; 19(3):914-21. PMID: 21861212.
    Citations: 16     Fields:    Translation:Humans
  152. Lin C, Buxton MB, Moore D, Krontiras H, Carey L, DeMichele A, Montgomery L, Tripathy D, Lehman C, Liu M, Olapade O, Yau C, Berry D, Esserman LJ. Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res Treat. 2012 Apr; 132(3):871-9. PMID: 21796368.
    Citations: 8     Fields:    Translation:Humans
  153. Loiselle CR, Eby PR, Kim JN, Calhoun KE, Allison KH, Gadi VK, Peacock S, Storer B, Mankoff DA, Partridge SC, Lehman CD. Can preoperative dynamic contrast-enhanced breast MRI predict extensive occult axillary lymph node metastases in patients with positive sentinel node biopsy? J Clin Oncol. 2011 May 20; 29(15_suppl):1049. PMID: 28020697.
    Citations:    
  154. Rahbar H, Partridge SC, Eby PR, Demartini WB, Gutierrez RL, Peacock S, Lehman CD. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol. 2011 Sep; 21(9):2011-9. PMID: 21562806.
    Citations: 20     Fields:    Translation:Humans
  155. Yau EJ, Gutierrez RL, DeMartini WB, Eby PR, Peacock S, Lehman CD. The utility of breast MRI as a problem-solving tool. Breast J. 2011 May-Jun; 17(3):273-80. PMID: 21477168.
    Citations: 5     Fields:    Translation:Humans
  156. Demartini WB, Kurland BF, Gutierrez RL, Blackmore CC, Peacock S, Lehman CD. Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics. Eur Radiol. 2011 Aug; 21(8):1609-17. PMID: 21359910.
    Citations: 4     Fields:    Translation:Humans
  157. Partridge SC, Rahbar H, Murthy R, Chai X, Kurland BF, DeMartini WB, Lehman CD. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med. 2011 Jun; 65(6):1759-67. PMID: 21254208.
    Citations: 32     Fields:    Translation:Humans
  158. Loiselle CR, Eby PR, Peacock S, Kim JN, Lehman CD. Dynamic contrast-enhanced magnetic resonance imaging and invasive breast cancer: primary lesion kinetics correlated with axillary lymph node extracapsular extension. J Magn Reson Imaging. 2011 Jan; 33(1):96-101. PMID: 21182126.
    Citations: 3     Fields:    Translation:Humans
  159. Gutierrez RL, DeMartini WB, Silbergeld JJ, Eby PR, Peacock S, Javid SH, Lehman CD. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging. AJR Am J Roentgenol. 2011 Jan; 196(1):W93-9. PMID: 21178040.
    Citations: 10     Fields:    Translation:Humans
  160. Loving VA, DeMartini WB, Eby PR, Gutierrez RL, Peacock S, Lehman CD. Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications. AJR Am J Roentgenol. 2010 Dec; 195(6):1472-7. PMID: 21098212.
    Citations: 3     Fields:    Translation:Humans
  161. DeMartini WB, Ichikawa L, Yankaskas BC, Buist D, Kerlikowske K, Geller B, Onega T, Rosenberg RD, Lehman CD. Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium. J Am Coll Radiol. 2010 Nov; 7(11):878-84. PMID: 21040870.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  162. Partridge SC, Vanantwerp RK, Doot RK, Chai X, Kurland BF, Eby PR, Specht JM, Dunnwald LK, Schubert EK, Lehman CD, Mankoff DA. Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer. J Magn Reson Imaging. 2010 Nov; 32(5):1124-31. PMID: 21031518.
    Citations: 18     Fields:    Translation:Humans
  163. Allison KH, Eby PR, Kohr J, DeMartini WB, Lehman CD. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol. 2011 Jan; 42(1):41-50. PMID: 20970167.
    Citations: 8     Fields:    Translation:Humans
  164. Strigel RM, Eby PR, Demartini WB, Gutierrez RL, Allison KH, Peacock S, Lehman CD. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI. AJR Am J Roentgenol. 2010 Sep; 195(3):792-8. PMID: 20729462.
    Citations: 7     Fields:    Translation:Humans
  165. Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith-Bindman R, Lehman C, Weaver D, Carney PA, Barlow WE. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. J Natl Cancer Inst. 2010 Jul 21; 102(14):1040-51. PMID: 20601590.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  166. Liu F, Kanal KM, Stewart BK, Lehman CD. Effects of lesion positioning on digital magnification mammography performance. Acad Radiol. 2010 Jun; 17(6):791-4. PMID: 20399685.
    Citations: 1     Fields:    Translation:Humans
  167. Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, Lehman CD. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol. 2010 Jun; 194(6):1664-73. PMID: 20489111.
    Citations: 47     Fields:    Translation:Humans
  168. Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667. Radiology. 2010 Jun; 255(3):731-7. PMID: 20501712.
    Citations: 13     Fields:    Translation:Humans
  169. Eby PR, DeMartini WB, Gutierrez RL, Lehman CD. Probably benign lesions detected on breast MR imaging. Magn Reson Imaging Clin N Am. 2010 May; 18(2):309-21, x. PMID: 20494314.
    Citations: 1     Fields:    Translation:Humans
  170. Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging. 2010 Mar; 31(3):562-70. PMID: 20187198.
    Citations: 42     Fields:    Translation:Humans
  171. Kohr JR, Eby PR, Allison KH, DeMartini WB, Gutierrez RL, Peacock S, Lehman CD. Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology. 2010 Jun; 255(3):723-30. PMID: 20173103.
    Citations: 10     Fields:    Translation:Humans
  172. Partridge SC, Ziadloo A, Murthy R, White SW, Peacock S, Eby PR, DeMartini WB, Lehman CD. Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors. J Magn Reson Imaging. 2010 Feb; 31(2):339-47. PMID: 20099346.
    Citations: 26     Fields:    Translation:Humans
  173. Partridge SC, Murthy RS, Ziadloo A, White SW, Allison KH, Lehman CD. Diffusion tensor magnetic resonance imaging of the normal breast. Magn Reson Imaging. 2010 Apr; 28(3):320-8. PMID: 20061111.
    Citations: 24     Fields:    Translation:Humans
  174. Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010; 2010(41):150-1. PMID: 20956821.
    Citations: 13     Fields:    Translation:Humans
  175. Eby PR, Calhoun KE, Kurland BF, Demartini WB, Gutierrez RL, Peacock S, Anderson BO, Byrd DR, Mann GN, Lehman CD. Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips. Acad Radiol. 2010 Mar; 17(3):340-7. PMID: 20042350.
    Citations: 2     Fields:    Translation:Humans
  176. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol. 2009 Dec; 193(6):1716-22. PMID: 19933670.
    Citations: 73     Fields:    Translation:Humans
  177. Lehman CD, Smith RA. The role of MRI in breast cancer screening. J Natl Compr Canc Netw. 2009 Nov; 7(10):1109-15. PMID: 19930977.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  178. Gutierrez RL, Demartini WB, Eby P, Kurland BF, Peacock S, Lehman CD. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Acad Radiol. 2009 Oct; 16(10):1281-5. PMID: 19733804.
    Citations: 4     Fields:    Translation:Humans
  179. Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol. 2009 Oct; 193(4):994-1000. PMID: 19770321.
    Citations: 30     Fields:    Translation:Humans
  180. Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD. Characteristics of probably benign breast MRI lesions. AJR Am J Roentgenol. 2009 Sep; 193(3):861-7. PMID: 19696303.
    Citations: 16     Fields:    Translation:Humans
  181. Wang LC, DeMartini WB, Partridge SC, Peacock S, Lehman CD. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation. AJR Am J Roentgenol. 2009 Sep; 193(3):826-31. PMID: 19696298.
    Citations: 16     Fields:    Translation:Humans
  182. Gallagher TH, Cook AJ, Brenner RJ, Carney PA, Miglioretti DL, Geller BM, Kerlikowske K, Onega TL, Rosenberg RD, Yankaskas BC, Lehman CD, Elmore JG. Disclosing harmful mammography errors to patients. Radiology. 2009 Nov; 253(2):443-52. PMID: 19710002.
    Citations: 2     Fields:    Translation:Humans
  183. Loiselle CR, Eby PR, DeMartini WB, Peacock S, Bittner N, Lehman CD, Kim JN. Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1314-9. PMID: 19604652.
    Citations: 4     Fields:    Translation:Humans
  184. Demartini WB, Eby PR, Peacock S, Lehman CD. Utility of targeted sonography for breast lesions that were suspicious on MRI. AJR Am J Roentgenol. 2009 Apr; 192(4):1128-34. PMID: 19304724.
    Citations: 16     Fields:    Translation:Humans
  185. Lehman CD, DeMartini W, Anderson BO, Edge SB. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw. 2009 Feb; 7(2):193-201. PMID: 19200417.
    Citations: 26     Fields:    Translation:Humans
  186. Eby PR, Ochsner JE, DeMartini WB, Allison KH, Peacock S, Lehman CD. Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge. AJR Am J Roentgenol. 2009 Jan; 192(1):229-34. PMID: 19098204.
    Citations: 14     Fields:    Translation:Humans
  187. Eby PR, Partridge SC, White SW, Doot RK, Dunnwald LK, Schubert EK, Kurland BF, Lehman CD, Mankoff DA. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer. Acad Radiol. 2008 Oct; 15(10):1246-54. PMID: 18790395.
    Citations: 11     Fields:    Translation:Humans
  188. Atkinson C, Newton KM, Aiello Bowles EJ, Lehman CD, Stanczyk FZ, Westerlind KC, Li L, Lampe JW. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States. Breast Cancer Res Treat. 2009 Aug; 116(3):587-94. PMID: 18821061.
    Citations: 13     Fields:    Translation:Humans
  189. Eby PR, Ochsner JE, DeMartini WB, Allison KH, Peacock S, Lehman CD. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy? Ann Surg Oncol. 2008 Nov; 15(11):3232-8. PMID: 18696163.
    Citations: 1     Fields:    Translation:Humans
  190. DeMartini W, Lehman C. A review of current evidence-based clinical applications for breast magnetic resonance imaging. Top Magn Reson Imaging. 2008 Jun; 19(3):143-50. PMID: 18941394.
    Citations: 24     Fields:    Translation:Humans
  191. Eby PR, Lehman CD. Magnetic resonance imaging--guided breast interventions. Top Magn Reson Imaging. 2008 Jun; 19(3):151-62. PMID: 18941395.
    Citations: 5     Fields:    Translation:Humans
  192. DeMartini W, Lehman C, Partridge S. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol. 2008 Apr; 15(4):408-16. PMID: 18342764.
    Citations: 22     Fields:    Translation:Humans
  193. Buchholz TA, Lehman CD, Harris JR, Pockaj BA, Khouri N, Hylton NF, Miller MJ, Whelan T, Pierce LJ, Esserman LJ, Newman LA, Smith BL, Bear HD, Mamounas EP. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol. 2008 Feb 10; 26(5):791-7. PMID: 18258988.
    Citations: 38     Fields:    Translation:Humans
  194. Lehman CD, Rutter CM, Eby PR, White E, Buist DS, Taplin SH. Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography. AJR Am J Roentgenol. 2008 Feb; 190(2):511-5. PMID: 18212240.
    Citations: 4     Fields:    Translation:Humans
  195. Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J. 2007 Nov-Dec; 13(6):545-50. PMID: 17983393.
    Citations: 14     Fields:    Translation:Humans
  196. Eby PR, Demartini WB, Peacock S, Rosen EL, Lauro B, Lehman CD. Cancer yield of probably benign breast MR examinations. J Magn Reson Imaging. 2007 Oct; 26(4):950-5. PMID: 17896380.
    Citations: 11     Fields: